| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3158479 | Journal of Oral and Maxillofacial Surgery | 2009 | 4 Pages |
Abstract
While the implementation of deep vein thrombosis (DVT) prophylaxis in the hospital setting is a major concern, the use of antithrombotic agents is fraught with a variety of hemorrhagic complications. Due to increasing reports of adverse reactions to unfractionated heparin (UFH), several manufacturers have initiated product recalls. As a result, the use of low-molecular weight heparins (LMWHs) such as enoxaparin has risen substantially. In this paper, 2 orbital hemorrhagic complications in patients receiving enoxaparin therapy will be presented. The incidence of DVT in the OMS patient, recent prophylactic strategies, and their effectiveness will be reviewed.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Basem T. BDS, Robert J. DMD, MD, MSPH, Daniel DDS, MD, Allen DDS, Jurij R. MD,